Skip to main content

Table 4 Univariate analysis of baseline characteristics and mortality

From: The impact of albumin infusion on the risk of rebleeding and in-hospital mortality in cirrhotic patients admitted for acute gastrointestinal bleeding: a retrospective study of a single institute

 No death
(n = 1422)
Death
(n = 81)
P value
Age53.0 ± 13.054.2 ± 13.50.444
Gender (M)947 (66.6)58 (71.6)0.418
Child-Pugh classification  < 0.001
 A469 (33.0)5 (6.2) 
 B689 (48.5)26 (32.1) 
 C264 (18.6)50 (61.7) 
Hepatic encephalopathy94 (6.6)29 (35.8)< 0.001
Ascites738 (51.9)12 (14.8)< 0.001
Rebleeding79 (5.6)67 (82.7)< 0.001
Sources of bleeding
 Varies lesion1215 (85.4)60 (74.1)0.009
 Non-varices lesion99 (7.0)1 (1.2)0.075
 Lower gastrointestinal lesion45 (3.2)2 (2.5)0.983
 Unidentified lesion109 (7.7)19 (23.5)< 0.001
Bilirubin (umol /L) a31.8 ± 39.074.1 ± 116.7< 0.001
Albumin (g/L) a30.9 ± 6.126.6 ± 6.5< 0.001
Creatine (mol/L) a79.7 ± 58.4114.0 ± 80.0< 0.001
Hemoglobin (g/L) a75.7 ± 22.874.6 ± 24.00.683
Prothrombin time (s) a16.5 ± 9.521.0 ± 13.4< 0.001
Balloon tamponade133 (9.4)36 (44.4)< 0.001
Endoscopic treatment507 (35.7)4 (4.9)< 0.001
Radiological intervention381 (26.8)1 (1.2)< 0.001
  1. avalues were obtained at admission